Prospective trial of ossein-hydroxyapatite compound in surgically induced postmenopausal women

Bone

Volumn 10, Issue 3, 1989, Pages 179-185

  Stepan J J ^a   Pospichal J ^a   Presl, J ^a   Pacovsky V ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Acid phosphatase; Alkaline phosphatase; Bone; Calcium; Hydroxyproline; Oophorectomy

Indexed keywords

ACID PHOSPHATASE; ALKALINE PHOSPHATASE; HYDROXYPROLINE;

CALCIUM BONE LEVEL; CLINICAL ARTICLE; ETHNIC OR RACIAL ASPECTS; ETIOLOGY; FEMALE; HUMAN; HUMAN CELL; OVARIECTOMY;

ALKALINE PHOSPHATASE; BONE RESORPTION; CLINICAL TRIALS; COLLAGEN; CREATININE; FEMALE; HUMAN; HYDROXYAPATITES; HYDROXYPROLINE; ISOENZYMES; MENOPAUSE; MIDDLE AGE; OVARIECTOMY; PROSPECTIVE STUDIES;

EID: 0024429382     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/8756-3282(89)90051-3     Document Type: Article

References (28)

1. The influence of ossein-hydroxyapatite compound “Ossopan” on the healing of a bone defect
2. Linear one-step assay for the determination of orthophosphate
3. Absorption intestinale de gluconate de calcium et de complexe osseino-mineral: évaluation par des dosages conventionnels
4. The role of skeletal calcium deficiency in postmenopausal osteoporosis
5. Therapy of osteoporosis with an ossein-hydroxyapatite-compound evaluated with quantitative computed tomography
6. Calcium metabolism in bone disease: effect of treatment with microcrystalline calcium hydroxyapatite and dihydrotachysterol
7. Vitamin D, hydroxyapatite, and calcium gluconate in treatment of cortical bone in postmenopausal women with primary biliary cirrhosis
8. Evidence of estrogen receptors in normal human osteoblast-like cells
9. Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium
10. Menopausal changes in calcium balance performance
11. Effect of calcium supplementation on urinary hydroxyproline in osteoporotic postmenopausal women
12. Prospective trial of oestrogen and calcium in postmenopausal women
13. Prevention of spinal osteoporosis in oophorectomized women
14. Direct colorimetric determination of serum calcium with ocresolphathalein complexon
15. Microcrystalline calcium hydroxyapatite in corticosteroid-treated rheumatoid patients: a controlled study
16. Coherence therapy does not prevent axial bone loss in osteoporotic women: a preliminary comparative study
17. Morphologic basis of bone mineral measurements: transient and steady state effects of treatment in osteoporosis
18. Diagnostic value of bone histomorphometry and comparison of histologic measurements and biochemical indices of bone remodeling
19. The relation between plasma androstendione, plasma oestrone and androstendione to oestrone conversion rates in post-menopausal women with and without fractures
20. Effect of calcium supplementation on forearm bone mineral content in postmenopausal women: a prospective, sequential controlled trial
21. Effect of estrogens and calcium carbonate on bone loss in postmenopausal women
22. Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy
23. Does calcium supplementation prevent postmenopausal bone loss? A double-blind, controlled clinical study
24. Microcrystalline hydroxyapatite compound in prevention of bone loss in corticosteroid-treated patients with chronic active hepatitis
25. Bone loss and biochemical indices of bone remodeling in surgically induced postmenopausal women
26. Serum osteocalcin levels and bone alkaline phosphatase isoenzyme after oophorectomy and in primary hyperparathyroidism
27. Nomogram for derivation of renal threshold phosphate concentration